SUNPHARMA

Pharma giant Sun Pharmaceutical Industries is in the spotlight after strong market momentum and continued investor interest following its major global acquisition moves and sector-wide rally. The stock recently outperformed several pharma peers and is trading close to its 52-week high, showing strong bullish sentiment in the pharma sector. Why Sun Pharma is trending: • Strong momentum in pharma stocks • Stock trading near 52-week highs • Benefiting from rupee weakness and export tailwinds • Continued focus after major international acquisition activity Experts believe the Indian pharma sector could remain strong as export-oriented companies benefit from currency movement and growing global demand. Market Buzz: Pharma stocks are seeing renewed buying interest as investors rotate toward defensive and export-driven sectors amid global uncertainty.